Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine Therapy in Obsessive-compulsive Disorder and Its Effects on Neuropsychological Function Under Stress in a Cross-over Trial


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05577585

Organisation Name: Medical University of Vienna

Overal Status: Recruiting

Start Date: August 1, 2022

Last Update: October 13, 2022

Lead Sponsor: Medical University of Vienna

Brief Summary: The main goal of this trial is to demonstrate therapeutic efficacy of low dose ketamine in patients with OCD. We expect that ketamine will alleviate symptoms in the hours following application, but also - if effective - that the anti-OCD effects might last for several days after a single infusion.

Conditions:
  • Obsessive-Compulsive Disorder
  • Psychiatric Disorder


Total execution time in seconds: 0.30164813995361